Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"JSC Olainfarm","sponsor":"Not Applicable","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"JSC Olainfarm & Adalvo to Launch a New Urology Product in 17 Countries In 2022-2023","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Approved","country":"LATVIA","productType":"Small molecule","productStatus":"Approved","date":"June 2021","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Approved"}]

    Find Clinical Drug Pipeline Developments & Deals for MolPort-001-779-607

    Menu

    MolPort-001-779-607

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              JSC Olainfarm

              Contact Supplier
              • Deals
              Virtual BoothOlainfarm is one of the leading pharmaceutical companies in the Baltic States and Northern Europe, with almost 50 years of experience.
              Contact Supplier Contact Supplier
              Flag Latvia
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              JSC Olainfarm & Adalvo to Launch a New Urology Product in 17 Countries In 2022-2023

              Details:

              In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support market activities.

              Lead Product(s): Furazidin

              Therapeutic Area: Infections and Infectious Diseases Product Name: Furagins

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement June 16, 2021

              JSC OlainFarm Company Banner

              Iran Expo

              Not Confirmed

              envelop Contact Supplier
              Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.
              ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
              Post Enquiry
              POST ENQUIRY